REsPonse to Interferon-Alpha in InterfeRon-beta Neutralizing Antibody Positive Multiple Sclerosis Patients.
Phase of Trial: Phase II
Latest Information Update: 11 Feb 2013
At a glance
- Drugs Interferon alpha (Primary) ; Interferon beta-1a; Interferon beta-1b
- Indications Multiple sclerosis
- Focus Biomarker; Pharmacodynamics
- Acronyms REPAIR
- 07 Jun 2017 Biomarkers information updated
- 16 Jan 2013 Only treatment table updated, ex-Vans.
- 08 Aug 2011 Status changed from recruiting to completed, as reported by ClinicalTrials.gov.